NIP
Nicholas Investment Partners’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.16M | Sell |
68,896
-18,072
| -21% | -$566K | 0.19% | 150 |
|
|
2025
Q1 | $2.92M | Buy |
86,968
+72,310
| +493% | +$2.43M | 0.3% | 117 |
|
|
2024
Q4 | $575K | Hold |
14,658
| – | – | 0.05% | 204 |
|
|
2024
Q3 | $577K | Buy |
+14,658
| New | +$577K | 0.05% | 202 |
|
|
2024
Q2 | – | Sell |
-167,926
| Closed | -$7.23M | – | 242 |
|
|
2024
Q1 | $7.23M | Buy |
167,926
+80,174
| +91% | +$3.45M | 0.74% | 41 |
|
|
2023
Q4 | $4.04M | Sell |
87,752
-766,695
| -90% | -$35.3M | 0.47% | 77 |
|
|
2023
Q3 | $29.2M | Buy |
854,447
+63,329
| +8% | +$2.16M | 2.18% | 9 |
|
|
2023
Q2 | $30.5M | Buy |
791,118
+354,403
| +81% | +$13.6M | 2.08% | 12 |
|
|
2023
Q1 | $15.6M | Buy |
436,715
+184,413
| +73% | +$6.6M | 1.19% | 30 |
|
|
2022
Q4 | $9.95M | Buy |
+252,302
| New | +$9.95M | 0.87% | 45 |
|